Douglas Emmett Inc Chairman Sells 62K Shares and 4 Insider Sales to Note

Emmett Dan A who is Chairman of the Board at Douglas Emmett Inc (NYSE:DEI), sold 62,000 shares at $23.86 per share for a total value of $1,479,320. The shares recently traded at $24.17, up $0.31, or 1.3% since the insider sale.

dei

Salame Mansour who is Director at 8×8 Inc. (NASDAQ:EGHT), sold 30,000 shares at $8.20 per share for a total value of $246,138. The shares recently traded at $8.12, down $0.08, or 0.98% since the insider sale.

eght

Lybarger Stanley A who is President & CEO at BOK Financial Corp. (NASDAQ:BOKF), sold 4,831 shares at $63.02 per share for a total value of $304,459. The shares recently traded at $62.63, down $0.39, or 0.62% since the insider sale.

bokf

Bozigian Haig P. who is Chief Development Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold 23,962 shares at $12.66 per share for a total value of $303,375. The shares recently traded at $12.6, down $0.06, or 0.47% since the insider sale.

Grigoriadis Dimitri E. who is Chief Research Officer at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold 25,937 shares at $12.68 per share for a total value of $328,931. The shares recently traded at $12.6, down $0.08, or 0.63% since the insider sale.

nbix

Don’t Miss: Starbucks Brews Up U.K. Taxes.

More Articles About:    

More from The Cheat Sheet